Product Name: HLA-DPB1 Antibody
Species Reactivity: Human
Tested Applications: IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 29 kDa
Immunogen: This HLA-DPB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 77-105 amino acids from the Central region of human HLA-DPB1.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 1018673-42-1
Product: Sugammadex (sodium)
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.45 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: HLA class II histocompatibility antigen, DP beta 1 chain, HLA class II histocompatibility antigen, DP(W4) beta chain, MHC class II antigen DPB1, HLA-DPB1, HLA-DP1B
Accession NO.: P04440
Protein Ino: 122263
Official Symbol: HLA-DPB1
Geneid: 3115
Background: HLA-DPB belongs to the HLA class II beta chain paralogues.This class II molecule is a heterodimer consisting of an alpha(DPA) and a beta chain (DPB), both anchored in the membrane. Itplays a central role in the immune system by presenting peptidesderived from extracellular proteins. Class II molecules areexpressed in antigen presenting cells (APC: B lymphocytes,dendritic cells, macrophages). The beta chain is approximately26-28 kDa and its gene contains 6 exons. Exon one encodes theleader peptide, exons 2 and 3 encode the two extracellular domains,exon 4 encodes the transmembrane domain and exon 5 encodes thecytoplasmic tail. Within the DP molecule both the alpha chain andthe beta chain contain the polymorphisms specifying the peptidebinding specificities, resulting in up to 4 different molecules.
PubMed ID:http://aac.asm.org/content/23/1/36.abstract
